Skip to main content
Premium Trial:

Request an Annual Quote

SciTegic Acquisition Helps Boost Accelrys Q4 Revenues 70 Percent

NEW YORK, May 12 (GenomeWeb News) - Accelrys reported 70-percent revenue growth amid narrowed losses for the fourth quarter of its 2005 fiscal year after market close today.

 

Accelrys said that sales from SciTegic, which it  acquired in September 2004, along with "strong growth" in sales of its core products, led to orders of $19.1 million for the quarter ended March 31, 2005, an 88-percent increase over $10.1 million in orders reported in the same period of 2004.

 

Reported revenue, which includes the impact of deferred revenue from the company's subscription accounting model, increased 70 percent to $18.9 million, from $11.1 million in the year-ago period.    

 

Accelrys did not break out quarterly orders or revenue numbers for SciTegic.

 

The company narrowed its net losses by 65 percent, to $9.3 million, or $.36 per share, for the current quarter, compared to $26.8 million, or $1.11 per share, for the quarter ended March 31, 2004.

 

R&D spending increased to $5.2 million, compared to $4.3 million in the year-ago period.

 

The company said that its expenses for the quarter included $1.5 million "for severance and related costs arising from a workforce reduction in March 2005," but did not provide further information on the layoffs in a conference call with analysts held after the earnings release.

 

Accelrys had cash, restricted cash, cash equivalents, and marketable securities of $63.3 million as of March 31.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.